RecruitingPhase 3NCT04782258
A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD)
Studying Autosomal recessive polycystic kidney disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Intervention
- Tolvaptan Suspension(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2028
Study locations (23)
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Emory University Hospital, Atlanta, Georgia, United States
- Northwestern University Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago - Neonatology, Chicago, Illinois, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- Children's Hospital - New Orleans, New Orleans, Louisiana, United States
- Johns Hopkins Pediatric Specialty Clinic, Baltimore, Maryland, United States
- C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States
- Mayo Clinic - Rochester, Rochester, Minnesota, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Cleveland Clinic, Cleveland, Ohio, United States
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
- Primary Children's Hospital, Salt Lake City, Utah, United States
- Université Catholique De Louvain And Cliniques St Luc, Brussels, Brussels Capital, Belgium
- Universitair Ziekenhuis Gent, Ghent, Oost-Vlaanderen, Belgium
- UZ Leuven, Leuven, Vlaams Brabant, Belgium
- +8 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04782258 on ClinicalTrials.govOther trials for Autosomal recessive polycystic kidney disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07201025Imaging Assessments of ARPKD Kidney Disease ProgressionThe Cleveland Clinic
- RECRUITINGNCT06601829Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University HospitalSohag University
- RECRUITINGNCT01401998ARPKD Database StudyChildren's Hospital of Philadelphia
See all trials for Autosomal recessive polycystic kidney disease →